 |
Regional trade association unites global MedTechs and local HealthTech startups to showcase solutions that empower patients to access affordable care - anywhere, anytime
Silicon Valley startup presents AI powered surgical blood loss measurement solution, while Singaporean startup reveals minimally invasive surgical robot for the first time at Asia Pacific MedTech Forum 2019.
SINGAPORE, Oct. 8, 2019 /PRNewswire/ -- On the eve of the fifth annual Asia Pacific MedTech Forum, regional medical technology association brings together twelve companies, across global MedTechs and local HealthTech startups, to present the APACMed Connected Care Innovation Showcase.
"The digitalization of healthcare encompasses the convergence of medical technologies, mobile devices, and aggregation platforms. As we prepare to host the region's largest MedTech conference for the 5th consecutive year in Singapore, we are proud to present how connected technologies from Medical IoT Wearables to Digital Health Apps can improve population health by shifting the burden of care from acute settings to home management of chronic disease," said Andrew Frye, Chairman, APACMed and President, Asia Pacific at Baxter.
Through the Showcase, APACMed plans to foster a dialogue between policy makers, payers, providers and patient advocacy groups on the future of connected technologies across the continuum of care.
"The Innovation Showcase provides a unique perspective on the potential of connected care, by bringing together stakeholders from across the ecosystem to demonstrate new approaches for solving today's diverse healthcare challenges," said Chng Kai Fong, Managing Director, Singapore Economic Development Board, "The APACMed Regulatory Summit is an ideal platform for the broader healthcare community, including regional policymakers and MedTech innovators, to explore opportunities for continued collaboration and partnership."
Building on the conference theme of 'Connecting Leaders, Connecting Care', these stakeholders were invited to discover how patients are becoming increasingly equipped to manage their own health data and personalise their care from hospital to home.
"This Showcase imagines those possibilities on a 2025 horizon as HealthTech startups and MedTech incumbents visualize this convergence of health technology, mobile devices and social media," said Harjit Gill, Chief Executive Officer, APACMed, "As patients transition from emergency rooms and the operating theatre into intensive care units, these innovators will present tech enable integrated care delivery that allows for remote monitoring, virtual consultations, diagnosis and treatment as future steps towards personalized medicine."
The APACMed Connected Care Innovation Showcase also highlights how the use of predictive analytics promises to accelerate clinician decision making in the operating theatre, while at the same time empowering patients to manage their personal health data in order to minimise the likelihood of hospital readmissions.
Paul Grand, Chief Executive Officer, MedTech Innovator, the medtech industry's leading global accelerator and venture competition added: "Our goal is to unearth the most promising startups around the globe and ensure that their transformative technologies reach patients and improve lives. I'm thrilled one of our 2019 Asia Pacific finalists will be featured in this Connected Care Showcase along with MedTech Innovator 2018 alumni to bring to life the transformative power of medical technologies."
In addition, local MedTech Innovators are also partnering with academia and research institutes to address the role of AI in an Emergency Department care setting.
Associate Professor Ng Wai Hoe, Medical Director National Neuroscience Institute (NNI), said "NNI is collaborating with Iota Medtech to advance diagnostics for better therapeutics through AI technology. This partnership presents new diagnostic and therapeutic possibilities in the management of conditions such as traumatic brain injury for better neuroscience care."
"With rising numbers in Singapore affected by neurological conditions, we must continue to improve and innovate care. A main concern for head injuries, currently the leading cause of disability and death for adults under 40 in Singapore, is time reduction in the acute treatment stage. Employing the use of AI technology can save critical time during diagnostics and transform care outcomes for patients," added A/Prof Ng Wai Hoe.
Recognising the rise of chronic diseases in Singapore and across the region, from diabetes to hypertension, MedTech innovators are seeking to alleviate public health expenditures by leveraging technologies such as Medical IoT wearables and tele-health consultations with virtual clinicians to substantially reduce the rate of readmissions, while tilting the focus towards preventative healthcare.
About the Asia Pacific Medical Technology Association
Founded in 2014, the Asia Pacific Medical Technology Association (APACMed) is the first and only regional association to provide a unified voice for the medical technology industry in Asia Pacific. APACMed works proactively with bilateral, regional and local government bodies to shape policies, demonstrate the value of innovation and promote regulatory harmonisation. APACMed engages with medical device associations and companies in Asia Pacific to jointly advance regional issues, code of ethics and share best practices. Learn more about the association at www.apacmed.org
About The EDB
The Singapore Economic Development Board (EDB), a government agency under the Ministry of Trade and Industry, is responsible for strategies that enhance Singapore's position as a global centre for business, innovation, and talent. We undertake investment promotion and industry development, and work with international businesses, both foreign and local, by providing information, connection to partners and access to government incentives for their investments. Our mission is to create sustainable economic growth, with vibrant business and good job opportunities for Singapore.
About the National Neuroscience Institute
The National Neuroscience Institute (NNI) is the national specialist and regional centre of care for the brain, spine, nerve and muscle. NNI offers Neurology, Neurosurgery and Neuroradiology services with advanced technology and multi-disciplinary care teams. Committed to improving patients' lives, NNI aims to shape neuroscience for a better tomorrow through innovation, research and education. NNI is a member of the Singapore Health Services (SingHealth) – a public healthcare cluster which manages four hospitals, five specialty centres, eight polyclinics and a network of community hospitals. For more information, visit www.nni.com.sg.
About the MedTech Innovator Asia Pacific
Based in Los Angeles, Calif., MedTech Innovator is the premier non-profit startup accelerator in the medical technology industry. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator matches healthcare industry leaders with innovative early-stage and emerging growth medtech companies for mentorship and support. For more information about MedTech Innovator, visit https://medtechinnovator.org/
Logo - http://photos.prnasia.com/prnh/20150422/8521502487LOGO?lang=0
